INTERNATIONAL PATENT: NUTCRACKER THERAPEUTICS, INC. FILES APPLICATION FOR "MULTIPLE SPECIFIC ANTIBODIES TARGETING CD19, CD20 AND/OR CD47"

GENEVA, July 3 -- NUTCRACKER THERAPEUTICS, INC. (5858 Horton Street, Suite 540Emeryville, California 94608) filed a patent application (PCT/US2024/061467) for "MULTIPLE SPECIFIC ANTIBODIES TARGETING CD19, CD20, AND/OR CD47" on Dec 20, 2024. With publication no. WO/2025/137576, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SALLETS, Adrienne (c/o NUTCRACKER THERAPEUTICS, INC.5858 Horton Street, Suite 540Emeryville, California 94608), LOW, Ray (c/o NUTCRACKER THERAPEUTICS, INC.5858 Horton Street, Suite 540Emeryville, Calif...